Effectiveness of financial incentives for control of viral hepatitis among substance users: a systematic review and meta-analysis.

BACKGROUND

Hepatitis B virus (HBV) poses a significant global health challenge in substance users who are at a higher risk of infection. Financial incentives have been proposed as a strategy to enhance vaccine uptake among high-risk groups. This meta-analysis aims to assess the effectiveness of financial incentives in increasing HBV vaccination rates among substance users.

METHODS

A literature search across various databases was done for randomized controlled trials (RCTs) and non-randomized trials evaluating the impact of financial incentives on HBV vaccination rates in substance users. Six studies with a total of 3,886 participants were included. The GRADE approach was used to assess the quality of evidence, and a random-effects meta-analysis was done to calculate pooled risk ratios (RRs) for vaccination uptake.

RESULTS

Financial incentives were associated with a significant increase in the HBV vaccination uptake rates among substance users, with pooled RR of 2.261 (95% CI: 1.327-3.851), despite considerable heterogeneity (I = 93.7%). Sensitivity analysis confirmed the robustness of these findings. However, GRADE assessment indicated a very low quality of evidence, primarily due to risk of bias, inconsistency, imprecision, and potential publication bias, highlighted by a significant Luis Furuya-Kanamori (LFK) index of 6.42.

CONCLUSION

Financial incentives significantly improve HBV vaccination rates among substance users, underscoring their potential as a public health intervention in this high-risk population. Low quality of evidence calls for further high-quality RCTs to confirm these results and explore the most effective incentive strategies.

SYSTEMATIC REVIEW REGISTRATION

https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42024505277, identifier CRD42024505277.